![Page 1: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/1.jpg)
EMCDDA: case study on
reporting
Workshop working group 1.5, 2nd COPOLAD II Annual meeting
Ilze Jekabsone, Principal capacity development officer, EMCDDA
Lisbon 16 November 2017
![Page 2: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/2.jpg)
2
![Page 3: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/3.jpg)
Content of the presentation
• Brief overview of evolution of reporting
• Needs of audiences
• Content vs. ‘story’
• Final words
![Page 4: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/4.jpg)
Evolution of national reporting on drugs to
the EMCDDA
4
Reporting tools:- ST- SQ- National report- Special issue
Reporting tools
‘revamped’
- ST
- SQ
- 10 workbooks
Country level
outputs:
- National report
- EMCDDA
country
overview
- Other….
Country level outputs:- Joint EMCDDA and
national product –Country drug report
- Other ….
2015
20172000
2013
EDR
![Page 5: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/5.jpg)
‘Scientifically sound, evidence-based,
comparable’
• Agreed guidelines for reporting
• Sound data collection tools and methods
which allow comparability of data
• Quality assurance and feedback
Assessment of the implementation of the general population surveys key indicator
among adults (number of countries)
5
![Page 6: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/6.jpg)
Needs of audiencesWho they are?
What are their needs?
![Page 7: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/7.jpg)
What is your target audience?
![Page 8: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/8.jpg)
What are their needs?
![Page 9: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/9.jpg)
Format determined by target audience, the
objective and resources
• Length
• National reports in the past – around 100 pages
• CDR 2017 – around 20 pages
• European Drug Report – around 80 pages
• Output
• Word document
• Pdf version
• Printed
• ePub
• Other
![Page 10: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/10.jpg)
‘Shaping’ contentHuman resources
Guidelines
Infomap
Example: CDR2017
![Page 11: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/11.jpg)
Team
11
Team leaderData managers and analysts
Content experts
Communicator
Visual designer
Data and information providers
![Page 12: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/12.jpg)
Guidelines for reporting/content
• Main themes, which are detailed in questions
• Guidance for the use of data and statistics
• National vs local and regional data
• Scientific validity data, generalisability of data
• Guidance for ‘soft’ information
• Drug policy, research, interventions in demand and
supply areas
• Timeframe
• Descriptive analysis vs ‘creative approach’
• Proactive search for data, language, quotes,
conclusions
12
![Page 13: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/13.jpg)
InfoMap: sources
• Consistent with guidelines
• Use
• Consequences
• Markets
• Strategies and policies
• Responses
![Page 14: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/14.jpg)
Country drug report: setting the scene
At the glance: Latvia
![Page 15: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/15.jpg)
CDR: strategy and drug laws
• Scope of the
existing NDS
• Results of
evaluation
• National
coordination
mechanisms
• Penalties in law and
implementation
15
![Page 16: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/16.jpg)
• Number of drug law
offences and drug
law offenders
• Drug law offences
linked to each drug
• Use/possession-
and trafficking-
related drug-law
offences
CDR: drug law offences
16
![Page 17: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/17.jpg)
CDR: Drug use: prevalence
• Trends in 15-34 years old
and young people
• Minimum 3 data points
• Last-year use vs. Lifetime
use
• Complements with
wastewater and studies in
recreational environments
17
![Page 18: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/18.jpg)
CDR: high-risk drug use
• Main high risk use patterns and estimated populations
• Treatment request as high risk use proxy
18
![Page 19: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/19.jpg)
CDR: drug-related harms
Drug related infectious
diseases
• Notifications
• Prevalence among
PWID
• Drug related
emergencies
• Drug-induced
deaths and
mortality
19
![Page 20: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/20.jpg)
• Prevention
• Environmental
• Universal
• Selective
• Indicated
• Harm reduction
• Needle and syringe exchange
• Take home naloxone
• Drug consumption rooms
• Heroin assisted treatment
CDR: Responses
20
Provision of interventions in schools (expert rating)
![Page 21: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/21.jpg)
Treatment
21
• Policy
• Treatment system
• Treatment clients by
substances and
trends
• Opioid substitution
treatment
Latvia: treatment system
![Page 22: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/22.jpg)
Prisons:
- Drug use
- Response
Quality assurance
Drug-related research
Drug-related public
expenditure
Other areas
22
![Page 23: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/23.jpg)
Planning and monitoring – a half way to
success!
• Each phase detailed
• Timeline
• Milestones
• Responsible persons
• Involvement of key contributors
• Monitoring
23
![Page 24: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/24.jpg)
Key to success
• Corresponds to the needs and expectations
of your audiences
• Dedicated and competent team
• Provides comprehensive information on drug
situation in the country
• Quality of data and information
• Clear messages
• (Right) format
• (Right) dissemination
24
![Page 25: EMCDDA: case study on reporting - COPOLADsisco.copolad.eu/web/uploads/documentos/1.5_EMCDDA... · 2017-11-17 · EMCDDA: case study on reporting Workshop working group 1.5, 2nd COPOLAD](https://reader035.vdocuments.net/reader035/viewer/2022081607/5f020e7f7e708231d4025c3a/html5/thumbnails/25.jpg)
emcdda.europa.eu
twitter.com/emcdda
facebook.com/emcdda
flickr.com/photos/emcdda
youtube.com/emcddatube
emcdda.europa.eu